Long-acting and implantable drug delivery systems
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (15 March 2020) | Viewed by 670
Special Issue Editors
Interests: 3D printing; polymeric drug delivery systems; medical nanotechnology; transdermal drug delivery systems; microneedles; medical devices; implantable devices
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; hydrogels; biomaterials; 3D printing; biomass valorization; lignin
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is estimated that between 5 and 6% of people in industrialized countries have experienced the implantation of a medical device for rebuilding some body functions. These devices can be used for a wide variety of applications such as to replace a fraction of a biological structure or to provide a specific therapy. The latter application is particularly interesting, as long-acting and implantable drug delivery systems offer the possibility of providing localised and unattended therapy for a wide variety of conditions. These systems present multiple advantages over the conventional systems used for drug delivery and allow to reduce drug dosage while improving patient compliance. These features are particularly important for the treatment of chronic conditions. According to the World Health Organization, chronic conditions are the major cause of disabilities worldwide, and the burden of chronic diseases is increasing rapidly.
For this Special Issue, we encourage authors to submit research papers, communications or review articles describing the development of long-acting or implantable drug delivery systems, from the nanoscale (such as long-acting nanoparticle injections) up to the macroscale (i.e., solid implantable devices) size.
Dr. Eneko Larrañeta
Dr. Juan Dominguez-Robles
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- implantable devices
- long-acting drug delivery systems
- sustained drug delivery
- medical devices
